IP Library Granted Patent US 8,821,540
Granted Patent B2
US 8,821,540 · App. 12/850,063 · Granted Sep 2, 2014

Self-retaining sutures having effective holding strength and tensile strength

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,821,540
App. No.
12/850,063
Granted
Sep 2, 2014
Kind
B2
Abstract

A barbed suture with a first end and a second end and a body with a plurality of barbs extending from the body. Each barb causes the suture to resist movement in an opposite direction from which the barb faces. Projections extend from said suture. The projections can also engage tissue. The barbs cover the projections when the first end of the suture is moved in tissue and exposes the projections in order to engage tissue when the suture is moved in the direction of the second end through tissue.

Claims (20)

1. A self-retaining suture formed from stock monofilament of a bioabsorbable polymer, the stock monofilament having a filament diameter (SD) and a tensile strength, wherein the self-retaining suture comprises: a strand of said stock monofilament, the strand having a first end, a second end, a longitudinal axis, and a surface; a plurality of cuts made into the surface of the strand; the cuts extending from a beginning at the surface to an end within the strand, the plurality of cuts defining a plurality of barbs adapted to permit movement of the strand through tissue towards the first end and resist movement in an opposite direction; each barb having a tip separated from the strand and a base connected to the strand at the end of the cut, and further having an underside which attaches the barb to the strand along a concave arcuate line; each barb having a length no less than about 0.8 filament diameters (0.8*SD), measured tip-to-base along the longitudinal axis; adjacent barbs being distributed at a spacing no larger than two filament diameters (2*SD), measured tip-to-tip along the longitudinal axis; each barb having a ratio of cut depth to SD from about 0.05 to about 0.5; each barb having a cut angle formed between the barb and the strand from about 140 degrees to about 175 degrees; and the self-retaining suture having a tensile strength no less than about one third of the tensile strength of the stock monofilament from which the self-retaining suture is made.

2. The self-retaining suture of claim 1 , wherein the spacing between adjacent barbs is less than about one-and-a-half filament diameters (1.5*SD).

3. The self-retaining suture of claim 2 , wherein the filament diameter (SD) is less than about 1 mm.

4. The self-retaining suture of claim 3 , wherein the spacing between adjacent barbs is less than about 1 mm.

5. The self-retaining suture of claim 4 , wherein the filament diameter (SD) is less than about 0.5 mm.

6. The self-retaining suture of claim 1 , wherein each barb has a length no less than about one filament diameter (1*SD).

7. The self-retaining suture of claim 1 , wherein the plurality of barbs includes a first set of barbs, a second set of barbs and a third set of barbs, the first set of barbs being radially displaced by 120 degrees from the second set of barbs, the third set of barbs being radially displaced by 120 degrees from first set of barbs and from the second set of barbs.

8. The self-retaining suture of claim 1 , wherein the self-retaining suture has a tensile strength at least substantially equivalent to a USP minimum knot pull strength requirement for an unbarbed suture made from the same stock monofilament.

9. The self-retaining suture of claim 1 , wherein the self-retaining suture has a tensile strength greater than 7 pounds.

10. The self-retaining suture of claim 1 , wherein the bio-absorbable polymer is a polymer of at least one monomer selected from the group consisting of: dioxanone; lactide; glycolide; and caprolactone.

11. The self-retaining suture of claim 1 , wherein the bio-absorbable polymer comprises a copolymer of glycolide and trimethylene carbonate.

12. The self-retaining suture of claim 1 , wherein the tip of each barb is pointed.

13. A wound-closure device formed from stock monofilament of a bioabsorbable polymer, the stock monofilament being elongate and flexible and having a filament diameter (SD) and a tensile strength, wherein the wound-closure device comprises: a strand of said stock monofilament, the strand having a first end, a second end, a longitudinal axis, and a surface; a plurality of cuts made into the surface of the strand; the cuts extending from a beginning at the surface to an end within the strand, the plurality of cuts defining a plurality of projections adapted to permit movement of the strand through tissue towards the first end and resist movement in an opposite direction; each projection having an apex separated from the strand and a base connected to the strand at the end of the cut that defines the projection, and further having an underside which attaches the projection to the strand along a concave arcuate line; each projection having a length no less than about 0.8 filament diameters (0.8*SD), measured apex-to-base along the longitudinal axis; adjacent projections being distributed at a spacing no larger than two filament diameters (2*SD), measured apex-to-apex along the longitudinal axis; each projection having a ratio of cut depth to SD from about 0.05 to about 0.5; and each projection having a cut angle formed between the projection and the strand from about 140 degrees to about 175 degrees.

14. The wound-closure device of claim 13 , wherein the plurality of projections includes a first set of at least thirty projections, a second set of at least thirty projections and a third set of at least thirty projections, the first set of at least thirty projections being radially displaced by 120 degrees from the second set of at least thirty projections, the third set of at least thirty projections being radially displaced by 120 degrees from the first set of at least thirty projections and from the second set of at least thirty projections.

15. The wound-closure device of claim 13 , wherein each projection has a length no less than about one filament diameter (1*SD).

16. The wound-closure device of claim 13 , wherein the wound-closure device has a tensile strength at least substantially equivalent to a USP minimum knot pull strength requirement for a suture made, without such projections, from the same stock monofilament.

17. The wound-closure device of claim 13 , wherein the wound-closure device has a tensile strength greater than seven pounds.

18. The wound-closure device of claim 13 , wherein each apex is pointed.

19. The wound-closure device of claim 13 , wherein each projection comprises a barb.

20. A wound-closure device formed from stock monofilament of a bioabsorbable polymer, the stock monofilament being elongate and flexible and having a filament diameter (SD) less than 1 mm, wherein the wound-closure device comprises: a strand of said stock monofilament, the strand having a first end, a second end, a longitudinal axis, and a surface; a plurality of cuts made into the surface of the strand; the cuts extending from a beginning at the surface to an end within the strand, the plurality of cuts defining a plurality of projections adapted to permit movement of the strand through tissue towards the first end and resist movement in an opposite direction; each projection having an apex separated from the strand and a base connected to the strand at the end of the cut that defines the projection, and further having an underside which attaches the projection to the strand along a concave arcuate line; each projection having a length no less than about 0.8 filament diameters (0.8*SD), measured apex-to-base along the longitudinal axis; adjacent projections being distributed at a spacing no larger than two filament diameters (2*SD), measured apex-to-apex along the longitudinal axis; each projection having a ratio of cut depth to SD from about 0.05 to about 0.5; each projection having a cut angle formed between the projection and the strand from about 140 degrees to about 175 degrees; and the wound-closure device having a tensile strength greater than 7 lbs.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2013
From: WELLS FARGO CAPITAL FINANCE, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030211/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: ANGIOTECH PHARMACEUTICALS, INC.; QUILL MEDICAL, INC.
To: ETHICON, INC.; ETHICON, LLC
Reel/Frame 029294/0443 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded May 16, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028216/0499 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded Apr 20, 2012
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028078/0699 →
PARTIAL RELEASE OF SECURITY INTEREST - PATENTS Recorded Apr 10, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028022/0861 →
PATENT SECURITY AGREEMENT Recorded May 13, 2011
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH DELAWARE, INC.; ANGIOTECH FLORIDA HOLDINGS, INC.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026275/0507 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2010
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDIA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALITIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 024861/0219 →